Skip to main content

Seizure Frequency as Treatment Effect Parameter: General Considerations

  • Chapter
Quantitative Assessment in Epilepsy Care

Part of the book series: NATO ASI Series ((NSSA,volume 255))

  • 62 Accesses

Abstract

As epilepsy is a paroxysmal disorder it seems self-evident that the frequency of occurrence of paroxysms is a sensible index. However, as Feinstein admonishes in his teachings on clinimetrics, the first question to be asked is for what purpose do we intend to use the index.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. Meinardi, Clinical trials of anti-epileptic drugs, Psychiat.Neurol.Neurochir. 74, 141, (1971).

    PubMed  CAS  Google Scholar 

  2. J.A. Cramer, D.B. Smith, R.H. Mattson et al. A method of quantification for the evaluation of anti-epileptic drugtherapy. Neurology 33(suppl.): 26–37 (1983)

    Article  PubMed  CAS  Google Scholar 

  3. A.R. Feinstein, Clinimetrics. Yale University Press, New Haven (1987).

    Google Scholar 

  4. N. Ilium, K. Taudorf, C. Heilmann,et.al Intravenous immunoglobulin in a single-blind trial in children with Lennox-Gastaut syndrome,Neuropediatrics. 21:87 (1990).

    Article  PubMed  Google Scholar 

  5. D.J.P. Wijsman, Y.A. Hekster, A. Keyser et al., Clinimetrics and epilepsy care, Pharm. Weekbl. [Sc.], 13: 182, (1991).

    Article  CAS  Google Scholar 

  6. J. Overweg, D. Ashton, F. de Beukelaar, et al., Add-on therapy in epilepsy with calcium entry blockers, Eur. Neurol.: 25 suppl.1:93, (1986).

    Article  Google Scholar 

  7. E.H. Reynolds, S.D. Shorvon, A.W. Galbraith et al. Phenytoin monotherapy for epilepsy: a longterm prospective study, assisted by serum level monitoring, in previously untreated patients. Epilepsia 22: 475, (1981).

    Article  PubMed  CAS  Google Scholar 

  8. D.F. Smith, G.A. Baker, M. Dewey, et al., Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epilepsy Res. 9: 231, (1991).

    Article  PubMed  CAS  Google Scholar 

  9. J.S. Duncan, J.W.A.S. Sander, The Chalfont seizure severity scale, J. Neural., Neurosurg., and psychiatry 54: 873, (1991).

    Article  CAS  Google Scholar 

  10. G.A. Baker, D.F. Smith, M.Dewey et al., The development of a seizures severity scale as an outcome measure in epilepsy. Epilepsy Res. 8: 245, (1991).

    Article  PubMed  CAS  Google Scholar 

  11. A. Martins da Silva, E. Lourengo, J.M. Nunes and D. Mendonga, Seizure frequency as treatment effect parameter, this volume 35

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lammers, M.W., Meinardi, H. (1993). Seizure Frequency as Treatment Effect Parameter: General Considerations. In: Meinardi, H., Cramer, J.A., Baker, G.A., da Silva, A.M. (eds) Quantitative Assessment in Epilepsy Care. NATO ASI Series, vol 255. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2990-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2990-3_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6302-6

  • Online ISBN: 978-1-4615-2990-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics